Blog Archive

Search This Blog

Monday, July 31, 2017

Determination of Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day

Condition:   Oral Mucositis
Interventions:   Biological: AG013;   Other: Placebo
Sponsor:   Oragenics, Inc.
Recruiting - verified July 2017

from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2vlIP41

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Blog Archive

Pages

   International Journal of Environmental Research and Public Health IJERPH, Vol. 17, Pages 6976: Overcoming Barriers to Agriculture Green T...